Research News and Research

RSS

OctreoPharm Sciences granted SME status by the EMA

OctreoPharm Sciences GmbH, a medicine developer and specialist for radioactive labeled contrast agents in nuclear medicine has been granted SME status as small-sized enterprise in research and development by the European Medicine Agency EMA.

18 May 2011

Momentive Performance Materials collaborates with SSF to develop combination products

Momentive Performance Materials Inc. today announced a collaboration initiative with Specialty Silicone Fabricators (SSF) to develop combination products for medical devices manufacturers.

18 May 2011

InvoTek introduces new Safe Laser System for persons with limited movement

InvoTek, Inc., a research and development company in Alma, Arkansas, has launched a new product using safe laser technology that enables a person with limited movement to write, communicate, and control their environment. The product will be unveiled at the Abilities Expo 2011 in Newark, New Jersey on Friday, May 20, 2011.

18 May 2011

Probability of contamination during handshaking could be lower than is commonly perceived

Graduations are a celebration of achievement and growth, but could all the pomp and circumstance increase your risk of exposure to harmful bacteria? A team of researchers from the Johns Hopkins Bloomberg School of Public Health examined the risk of acquiring pathogenic bacteria such as Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) through shaking hands at graduation ceremonies across Maryland.

18 May 2011

Early childhood food allergies increase risk of severe allergy-related conditions and asthma later in life

Early results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies commonly occur in infants and toddlers, while environmental allergies, such as to dust, ragweed and mold, are more common in older children and adults.

From Quest Diagnostics 18 May 2011

Face masks worn by TB patients could cut transmission rates to non-infected patients

Face masks worn by patients infected with tuberculosis (TB) may be able to significantly cut transmission rates to non-infected patients, according to a new study by researchers from the U.S. and South Africa. The study was conducted in a specialized airborne infections research facility in South Africa, which was designed to allow study of methods to control the spread of TB.

18 May 2011

Study reveals weakness of pharmacies' clinical decision support software in evaluating drug-drug interactions

A study conducted at the University of Arizona College of Pharmacy found that only 28 percent of pharmacies' clinical decision support software systems - the computer programs that are in place to alert pharmacists to possible medication problems - correctly identified potentially dangerous drug-drug interactions.

18 May 2011

Scientists nail mechanism causing embryonic stem cells to differentiate into specialised cells

A team led by developmental biologist Professor Christophe Marcelle has nailed the mechanism that causes stem cells in the embryo to differentiate into specialised cells that form the skeletal muscles of animals' bodies.

18 May 2011

First Edition: May 18, 2011

Today's news highlights include reports about the latest developments regarding the budget talks and the Senate's "Gang of Six," the continuing political hijinx surrounding Medicare issues, and the Obama administration's plan to offer a new path for accountable care organizations.

18 May 2011

Affymetrix launches new menu of multiple genomic microarray tools

Affymetrix, Inc. today announced the availability of multiple genomic microarray tools that will further enable scientists in the applied research field.

18 May 2011

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

18 May 2011

Oak Point students raise $42,474.24 to combat cancer

Penny by penny, students at Oak Point Intermediate School in Eden Prairie, MN, raised an incredible $42,474.24 through Pennies for Patients, making them the top fundraiser nationwide in The Leukemia & Lymphoma Society's School & Youth Programs.

18 May 2011

Improved tissue grafts promote vascular growth in wound sites

Victims of third-degree burns and other traumatic injuries endure pain, disfigurement, invasive surgeries and a long time waiting for skin to grow back. Improved tissue grafts designed by Cornell scientists that promote vascular growth could hasten healing, encourage healthy skin to invade the wounded area and reduce the need for surgeries.

18 May 2011

Clinical PET system for early stage breast cancer diagnosis

European researchers have developed a clinical PET system with the highest resolution and sensitivity in the market, specifically dedicated to breast cancer detection in early stages.

18 May 2011

Gingrich focuses attention on aging research

The presidential hopeful urged more investment in Alzheimer's research as a step that would lead to savings down the road. Meanwhile, The AP reports how the tight budget could pit scientific priorities against each other in a funding competition.

18 May 2011

GOP intra-party divisions emerge over Medicare revamps

Rep. Paul Ryan, R-Wis., offered a forceful defense of his budget plan that includes a proposal to make major changes in the Medicare program after Newt Gingrich, the newly minted candidate for the Republican presidential nomination, ripped the plan.

18 May 2011

Aeterna Zentaris first quarter revenues increase to $7.4 million

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported financial and operating results as at and for the first quarter ended March 31, 2011.

18 May 2011

State efforts to protect patients fall short, group says

News reports examine the role of physician boards in protecting patients as well as how a self-referral rule is faring in the courts.

18 May 2011

Clinical data of Medtronic's Resolute drug-eluting stent in diabetes presented at EuroPCR meeting

For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent from Medtronic, Inc., provided remarkably safe and effective outcomes, according to the results of several studies presented today at EuroPCR, a major international meeting for cardiac and vascular specialists.

From Medtronic 18 May 2011

Clinipace Worldwide announces acquisition of PFC

Clinipace Worldwide, a global digital clinical research organization, and Swiss-based PFC Pharma Focus today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries.

18 May 2011